Hims & Hers Health, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Hims & Hers Health, Inc. (HIMS), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are HIMS insiders buying or selling?
Hims & Hers Health, Inc. insiders reported 9 open-market buys ($7.2M) and 315 sells ($386.8M) across 324 Form 4 filings — a net selling position of $379.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 20, 2026)
Insider sentiment
Net sellingNet insider flow of $379.6M in net selling. 1 insider buy in the last 90 days.
Recent HIMS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 7.2K | $31.99 | $229.2K |
| Jul 7, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 7.2K | $36.49 | $261.4K |
| Jun 23, 2026 | Patrick Harrison Carroll | Chief Medical Officer | Sale | 23.7K | $35.00 | $830.4K |
| Jun 23, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 18.2K | $34.03 | $619.2K |
| Jun 17, 2026 | Michael Chi | Chief Operating Officer | Sale | 14.0K | $31.50 | $441.9K |
| Jun 17, 2026 | Irene Becklund | PAO | Sale | 12.1K | $30.72 | $370.5K |
| Jun 17, 2026 | Mohamed Elshenawy | CTO | Sale | 30.0K | $31.50 | $946.3K |
| May 26, 2026 | David B Wells | Director | Purchase | 48.4K | $24.24 | $1.2M |
| May 19, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 8.0K | $23.64 | $187.9K |
| Apr 22, 2026 | Soleil Boughton | Chief Legal Officer | Sale | 9.5K | $30.00 | $283.9K |
| Apr 22, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 19.6K | $29.96 | $588.6K |
| Apr 20, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 54.9K | $26.53 | $1.5M |
| Apr 7, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 4.0K | $19.98 | $79.4K |
| Mar 24, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 9.2K | $23.77 | $219.1K |
| Mar 18, 2026 | Irene Becklund | PAO | Sale | 5.5K | $24.69 | $136.5K |
| Mar 18, 2026 | Soleil Boughton | Chief Legal Officer | Sale | 4.8K | $24.69 | $118.8K |
| Mar 18, 2026 | Michael Chi | Chief Operating Officer | Sale | 97.3K | $24.69 | $2.4M |
| Mar 2, 2026 | Soleil Boughton | Chief Legal Officer | Sale | 4.7K | $15.21 | $70.7K |
| Feb 4, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 5.3K | $26.44 | $139.1K |
| Jan 21, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 9.1K | $30.34 | $275.1K |
| Jan 7, 2026 | Oluyemi Okupe | Chief Financial Officer | Sale | 9.1K | $33.79 | $306.5K |
| Dec 23, 2025 | Oluyemi Okupe | Chief Financial Officer | Sale | 23.1K | $35.72 | $824.7K |
| Dec 18, 2025 | Michael Chi | Chief Operating Officer | Sale | 13.8K | $36.71 | $504.8K |
| Dec 18, 2025 | Deborah M. Autor | Chief Policy Officer | Sale | 7.1K | $36.71 | $259.0K |
| Dec 18, 2025 | Patrick Harrison Carroll | Chief Medical Officer | Sale | 10.0K | $36.71 | $367.9K |
Showing the 25 most recent of 324 Form 4 filings for Hims & Hers Health, Inc..
Most active HIMS insiders
- Soleil Boughton67 filings
- Oluyemi Okupe53 filings
- Andrew Dudum48 filings
- Michael Chi43 filings
- Irene Becklund36 filings
Ask anything about HIMS insider activity
Use Trabud's AI agent to query Hims & Hers Health, Inc.'s Form 4 history in plain English — "Show me HIMS CEO purchases this year" or compare it against any other ticker.
Open the AI agentHIMS insider trading FAQ
Are Hims & Hers Health, Inc. insiders buying or selling?
Across 324 SEC Form 4 filings, Hims & Hers Health, Inc. (HIMS) insiders reported 9 open-market purchases totaling $7.2M and 315 sales totaling $386.8M. That is a net selling position of $379.6M.
How many insiders trade HIMS stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Hims & Hers Health, Inc.. The most recent filing was accepted on Jul 20, 2026.
Where does Trabud get HIMS insider trading data?
All HIMS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.